| 【Company Research】Shenzhen Pagoda (2411 HK) – An ensuring 2022; and we remain positive for 2023 |
| 【Company Research】Kuaishou (1024 HK) – A solid start into 2023E |
| 【Company Research】China Feihe (6186 HK) – A 5%+ dividend yield looks attractive despite sluggish growth |
| 【Company Research】InnoCare Pharma (9969 HK) – Positive PoC data of orelabrutinib for MS |
| 【Company Research】Onewo (2602 HK) – Let Onewo Town Surprise you |
| 【Company Research】SenseTime (20 HK) – Leading in the China large AI model race |
| 【Company Research】AK Medical (1789 HK) – Higher growth certainty in 2023E |
| 【Company Research】Biocytogen (2315 HK) – Strong revenue growth in FY22 |
| 【Company Research】Sunny Optical (2382 HK) – NDR takeaways: a bumpy 1H23 ahead; Auto/VR/ AR business to drive long-term growth |
| 【Company Research】Greentown Service (2869 HK) – High brand quality to boost its 2023 recovery |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
